Suppr超能文献

中医药防治新型冠状病毒肺炎的研究进展

Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.

作者信息

Dai Yu-Jie, Wan Shi-Yao, Gong Shuai-Shuai, Liu Jin-Cheng, Li Fang, Kou Jun-Ping

机构信息

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.

出版信息

Chin J Nat Med. 2020 Dec;18(12):881-889. doi: 10.1016/S1875-5364(20)60031-0.

Abstract

Coronavirus disease-2019 (COVID-19) is a new highly infectious disease caused by a novel coronavirus. Recently, the number of new cases infected pneumonia in the world continues to increase, which has aroused great concern from the international community. At present, there are no small-molecule specific anti-viral drugs for the treatment. The high mortality rate seriously threatens human health. Traditional Chinese medicine (TCM) is a unique health resource in China. The combination of TCM and Western medicine has played a positive and important role in combating COVID-19 in China. In this review, through literature mining and analysis, it was found that TCM has the potential to prevent and treat the COVID-19. Then, the network pharmacological studies demonstrated that TCM played roles of anti-virus, anti-inflammation and immunoregulation in the management of COVID-19 via multiple components acting on multiple targets and multiple pathways. Finally, clinical researches also confirmed the beneficial effects of TCM on the treatment of patients. This review may provide meaningful and useful information on further drug development of COVID-19 and other viral infectious diseases.

摘要

新型冠状病毒肺炎(COVID-19)是一种由新型冠状病毒引起的新型高传染性疾病。近期,全球新型感染肺炎病例数持续增加,引起了国际社会的高度关注。目前,尚无用于治疗的小分子特异性抗病毒药物。高死亡率严重威胁人类健康。中医药是我国独特的卫生资源。中西医结合在中国抗击COVID-19中发挥了积极且重要的作用。在本综述中,通过文献挖掘与分析发现,中医药具有防治COVID-19的潜力。随后,网络药理学研究表明,中医药通过多种成分作用于多个靶点和多条途径,在COVID-19的治疗中发挥抗病毒、抗炎和免疫调节作用。最后,临床研究也证实了中医药对患者治疗的有益效果。本综述可能为COVID-19及其他病毒感染性疾病的进一步药物研发提供有意义且有用的信息。

相似文献

1
Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19.
Chin J Nat Med. 2020 Dec;18(12):881-889. doi: 10.1016/S1875-5364(20)60031-0.
6
The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule.
Biomed Pharmacother. 2021 Oct;142:111998. doi: 10.1016/j.biopha.2021.111998. Epub 2021 Aug 9.
7
Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.
Curr Med Chem. 2024;31(21):3118-3131. doi: 10.2174/0929867330666230331084126.
9
Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus (COVID-19).
Drug Dev Ind Pharm. 2020 Dec;46(12):1947-1959. doi: 10.1080/03639045.2020.1826510. Epub 2020 Oct 19.
10
Research progress of traditional Chinese medicine against COVID-19.
Biomed Pharmacother. 2021 May;137:111310. doi: 10.1016/j.biopha.2021.111310. Epub 2021 Feb 3.

引用本文的文献

2
4
Differences in emergency hospitalization trauma patients during and after the COVID-19 pandemic.
PLoS One. 2024 Dec 18;19(12):e0315416. doi: 10.1371/journal.pone.0315416. eCollection 2024.
5
Xuebijing Exerts Protective Effects on Myocardial Cells by Upregulating TRIM16 and Inhibiting Oxidative Stress and Apoptosis.
Curr Comput Aided Drug Des. 2025;21(4):503-516. doi: 10.2174/0115734099318323241122184120.
9
Diterpenoids target SARS-CoV-2 RdRp from the roots of Steud.
Front Plant Sci. 2024 Jul 25;15:1425759. doi: 10.3389/fpls.2024.1425759. eCollection 2024.
10

本文引用的文献

3
Traditional Chinese medicine for combating COVID-19.
Front Med. 2020 Oct;14(5):529-532. doi: 10.1007/s11684-020-0802-9. Epub 2020 Jul 23.
4
Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine.
J Integr Med. 2020 Jul;18(4):275-283. doi: 10.1016/j.joim.2020.04.001. Epub 2020 Apr 15.
5
Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19).
Am J Chin Med. 2020;48(4):763-777. doi: 10.1142/S0192415X2050038X. Epub 2020 Apr 29.
7
[Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1225-1231. doi: 10.19540/j.cnki.cjcmm.20200224.405.
9
In the eye of the COVID-19 cytokine storm.
Nat Rev Immunol. 2020 May;20(5):277. doi: 10.1038/s41577-020-0305-6.
10
3CL inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.
Pharmacol Res. 2020 Jun;156:104779. doi: 10.1016/j.phrs.2020.104779. Epub 2020 Apr 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验